Albany, NY -- (SBWIRE) -- 01/19/2019 -- The global Drugs Of Abuse Testing Market is driven by increasing consumption of illicit drugs. Growth of the market can also be attributed to high demand for drugs of abuse testing screening products from law enforcement agencies.
Testing for drugs of abuse is done in-house or onsite in order to detect drugs in the human body (saliva, blood, sweat) which are banned by the government for human consumption. The testing can be done using various technologies that involve rapid testing devices as well as analyzers which are laboratory instruments. Increasing demand for illicit drugs and increasing prevalence of drug addicts are driving the growth of the drugs of abuse testing market globally.
The global drugs of abuse testing market can be segmented based on product, sample type, testing type, end-user, and region. In terms of product, the global market can be classified into analyzers, rapid testing devices, and consumables. The consumables segment accounted for a major share of the global market in terms of revenue in 2017. The segment is projected to expand at a significant CAGR during the forecast period as consumables are used in every application for taking the sample. Consumables include fluid collection devices and other reagents used in performing a laboratory test. Rapid testing devices are convenient for carrying out the preliminary test for detection of drug in the human body owing to the portability of the devices. The test conducted using rapid testing devices usually denote positive or negative results. If further detailed investigation if required, then testing is done in laboratories using analyzers.
Request to View Sample of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1746
Based on sample type, the global drugs of abuse testing market can be segmented into saliva, blood, sweat & hair, urine, and breath. The urine segment accounted for a major share of 44% of the global drugs of abuse testing sample type segment in 2017, followed by the saliva segment with 24% market share. In terms of testing type, the global drugs of abuse market can be categorized into pain management testing, criminal justice testing, and work place screening. The criminal justice testing segment constituted 39% share of the global drugs of abuse testing market by test type in 2017. Based on end-user, the global drugs of abuse testing market can be bifurcated into forensic laboratories, diagnostic laboratories, on-the-spot testing, and forensic laboratories.
In terms of region, the global drugs of abuse testing market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global market and can be projected to gain market share by the end of 2026. The drugs of abuse testing market in North America is driven by high demand for rapid testing devices in the region, as the government is regularizing the rules and regulations for illicit drugs consumption. The drugs of abuse testing market in Europe is expected to grow significantly during the forecast period due to increasing incidence of abuse of prescription drugs in the region. North America is a highly attractive market and expected to increase at a significant CAGR during the forecast period due to rise in law enforcement for illicit drugs interdiction.
Request to View Brochure of Report -
https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1746
Major players operating in the global drugs of abuse testing market include Alere, Inc., Laboratory Corporation of America Holdings, Roche Diagnostics, Thermo Fisher Scientific Inc., Drägerwerk AG & Co. KGaA, Siemens Healthineers, Express Diagnostics International Inc. and Shimadzu Corporation. These companies have adopted the strategy of acquisition and collaboration in order to strengthen their position in the global market.